Genomic changes detected by oligo-array in malignant pleural effusion

L. D. Kulikowski, D. C. B. Rosolen, G. Bottura, F. S. Vargas, R. K. Sales, L. Antonangelo (Sao Paulo, Brazil)

Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session: Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Session type: E-Communication Session
Number: 3553
Disease area: Interstitial lung diseases, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. D. Kulikowski, D. C. B. Rosolen, G. Bottura, F. S. Vargas, R. K. Sales, L. Antonangelo (Sao Paulo, Brazil). Genomic changes detected by oligo-array in malignant pleural effusion. Eur Respir J 2010; 36: Suppl. 54, 3553

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Microsatellite alterations and cell free DNA analysis in malignant pleural effusion
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010


Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

Pleural fluid DNA integrity index as a diagnostic marker of malignant pleural effusion
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Cytology and DNA ploidy techniques in the diagnosis of malignant pleural effusion
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003

Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010


An algorithm for the investigation of isolated suspected malignant pleural effusions
Source: Eur Respir J 2003; 22: Suppl. 45, 541s
Year: 2003

Evaluation of pleural fluid human epididymis 4 (HE4) as a marker of malignant pleural effusions
Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions
Year: 2012


Transudative malignant pleural effusions
Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice?
Year: 2019



Management of malignant pleural effusion
Source: Eur Respir J 2001; 18: Suppl. 33, 397s
Year: 2001

Pleurodesis for malignant pleural effusion
Source: School Course 2014 - Medical Thoracoscopy
Year: 2014

Pleurodesis for malignant pleural effusion
Source: ERS Course 2016 - Skills course on medical thoracoscopy
Year: 2016

Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002

Management of malignant pleural effusions
Source: Guideline 2001
Year: 2001

Management of malignant pleural effusions
Source: ERS Skills course: Multi-disciplinary care in thoracic oncology
Year: 2019

Management of malignant pleural effusions
Source: Eur Respir J 2001; 18: 402-419
Year: 2001